Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name |
Funds holding | Growth | Growth % |
Fund value |
|
|---|---|---|---|---|---|---|
| 126 |
SCTX
126
Scribe Therapeutics Inc
SCTX
$393M
| – | – | – | – |
|
| 127 |
SGTX
127
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
| – | – | – | – |
|
| 128 |
SIOX
128
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| – | – | – | – |
|
| 129 |
SLBT
129
SL Science Holding Ltd
SLBT
$948M
| – | – | – | – |
|
| 130 |
SQZ
130
DELISTED
SQZ Biotechnologies Company
SQZ
| – | – | – | – |
|
| 131 |
TCRR
131
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| – | – | – | – |
|